Brii Biosciences Limited (HKG:2137)

Hong Kong · Delayed Price · Currency is HKD

1.380

+0.020 (1.45%)

Mar 6, 2026, 4:08 PM HKT

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Biotechnology (Startups)	54.99M	56.32M	-	92.54M	82.22M
Biotechnology (Startups) Growth	-2.36%	-	-	12.56%	307.10%
Biotechnology	-	-	122.28M	-	-
Total	54.99M	56.32M	122.28M	92.54M	82.22M
Total Growth	-2.36%	-53.94%	32.13%	12.56%	307.10%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
The People's Republic of China (The PRC)	617.00K	122.28M	92.54M	82.22M
The People's Republic of China (The PRC) Growth	-99.50%	32.13%	12.56%	307.10%
Total	617.00K	122.28M	92.54M	82.22M
Total Growth	-99.50%	32.13%	12.56%	307.10%

Source: S&P Global Market Intelligence.